Skip to content

Hugh Series

3 papers in the library · 57 citations · publishing 1994-1995

Papers

Sort Most recent Most cited

Behavioural and neuroendocrine responses to D-fenfluramine in rats treated with neurotoxic amphetamines

Journal of Psychopharmacology May 1, 1995 Hugh Series, Marisa Le Masurier, Sarah E. Gartside et al. 13 citations

The amphetamine derivatives p-chloroamphetamine (pCA), 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and D-fenfluramine can, if given repeatedly in high doses to rats, produce a degeneration of serotonergic nerve terminals which we have previously shown to result in a reduction in D-fenfluramine-evoked release of 5-HT in vivo. It is therefore possible that fenfluramine-evoked responses...

p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo.

Psychopharmacology December 1994 Hugh Series, P J Cowen, Trevor Sharp

Previous work has suggested that repeated treatment with substituted amphetamines including PCA, MDMA and d-fenfluramine produces a persistent neurodegeneration which is relatively selective for the fine serotoninergic terminals arising from the dorsal raphe nucleus. The aim of the present study was to investigate whether the acute releasing effect of d-fenfluramine might also be sensitive to...

Psychiatric complications of 'Ecstasy' use

Journal of Psychopharmacology 1994 Hugh Series, Sietske Boeles, Eluned Dorkins et al. 44 citations

Two case reports are presented of significant psychiatric disorders associated with ingestion of 'Ecstasy' (3,4-methylenedioxymethamphetamine), a recreational drug whose use appears to be increasing. In one case, the patient developed a brief paranoid psychosis which recurred and persisted for at least a month after he took a second dose of the drug. In the other, the patient experienced...